P330 Rate of disability at diagnosis in patients with inflammatory bowel diseases: Results from a prospective population-based inception cohort, IBD Prognosis Study
M Attauabi,G R Madsen,F Bendtsen,J Seidelin,J Burisch
DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0460
2024-01-01
Journal of Crohn's and Colitis
Abstract:Abstract Background Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), are chronic, progressive diseases associated with a high level of disability over time. In the current study, we aimed to investigate the occurrence of disability at the time of IBD diagnosis and determine its association with the initial disease presentation. Methods Incident adult patients (≥18 years old) with newly diagnosed UC or CD according to the Copenhagen IBD Criteria were included in the IBD Prognosis Study, a prospective, population-based, inception cohort covering a catchment areas of approximately 20% (1.1 million) of the Danish population. Disability was assessed using the validated IBD-Disability Index version 2.1 We defined no, moderate, and severe disability scores as 0-20, 36-50, and 51-100 points.2 A severe disease presentation was defined by the need for glucocorticoids, immunomodulators, biologics, or surgery within three months of disease. Multivariable logistical regression analyses were conducted by adjusting for gender, age, and IBD phenotype. Results Out of the original cohort, 208 (67.5%) and 128 (63.1%) patients with incident UC and CD, respectively, responded to the questionnaires. In comparison to non-responders, the former differed only in a higher proportion of female patients and never-smokers with UC, while a higher proportion of current smokers among patients with CD responded. The mean IBD Disability scores differed significantly between UC (24.2, standard deviation (SD) 18.1) and CD (28.8, SD 18.6, p=0.01), with every fourth and third patient, respectively, experiencing moderate or severe disability (moderate: UC: 9.9%, CD: 22.4%, p=0.002); severe: UC: 12.3%, CD: 11.2%, p=0.77). Independent factors associated with disability were extensive UC as well as female gender and extra-intestinal manifestations in both UC and CD (Table 1). In multivariable logistical regression analyses adjusting for age at disease onset, gender, and disease phenotype, severe disability was significantly associated with a severe initial presentation of IBD, including IBD-related hospitalization and initiation of biological therapies (Figure 1). Conclusion In this prospective population-based inception cohort of unselected patients with newly diagnosed IBD, we found every third and every fourth patient with UC and CD to experience moderate-to-severe disability at the time of diagnosis, which was independently associated with a severe disease presentation. These findings have implications for patient management and surveillance strategies. References 1 Peyrin-Biroulet L, et al. Gut. 2012. doi: 10.1136/gutjnl-2011-300049. 2 Gower-Rousseau C et al. Gut. 2017. doi: 10.1136/gutjnl-2015-310151.
gastroenterology & hepatology